Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
We’re here, working with the brightest minds in labs across the UK and Ireland, making life-saving breast cancer research happen.
The Molecular Cell Biology team are studying the cellular mechanisms that control the growth and spread of tumour cells.
Breast cancer is an incredibly diverse and complex disease, which means treatments that work for one patient won’t necessarily work for another. We need to identify the best way to select patients for the most appropriate treatment so that everyone can benefit from truly personalised medicine.
Women at high risk of developing breast cancer can take chemoprevention drugs, such as tamoxifen, to reduce their risk. However, chemoprevention will be effective for only some women.
We know that our genetics play a key role in determining breast cancer risk, but we need to know much more about the specific genes involved and how they affect an individual person’s risk.
Triple negative breast cancer is a sub-type of the disease for which there are currently no targeted treatments. In addition, this form of breast cancer can be more aggressive than others.
Triple negative breast cancer is a sub-type of the disease for which there are currently no targeted treatments. In addition, this form of breast cancer can be more aggressive than others.